The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- New platforms expand access to history
- Arab immigration archives and stories discussed
- Brazilian firm takes avocado to over 20 countries
- Brazil-Arab Gallery #75
- COP31: Algeria announces 14% emissions cut
- Europe drives growth in Brazilian footwear
- Arab-Brazilian Chamber takes firms for Food Africa
- Forest Fund close to starting operations

